FDAAPP / ONE TIME

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Before July 2027Before October 2027Before Jan 1, 2027Before Mar 1, 2027Before 2028

Kalshi

Loading chart…

$15,519 vol

79%Yes —No —

PriceContractsTotal

Trade YesLast 79¢

No resting orders on this market.

OutcomeChanceBuy

BJBefore July 2027

79%▼ 2

Yes 79¢No 21¢

BOBefore October 2027

90%

Yes 90¢No 10¢

BJBefore Jan 1, 2027

32%▲ 2

Yes 32¢No 68¢

Resolves Yes if the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.

View full rules Help centerReport Insider Trading

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Market Rules